Sign in

CIK 0001446847 · Accelerated filer<br>Smaller reporting company

IRONWOOD PHARMACEUTICALS INC

Sign in to watch
Ticker
IRWD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
043404176
Phone
617-621-7722
Business address
100 SUMMER STREET, SUITE 2300, BOSTON, MA, 02110
  1. 4 Grant or award Director acquired 45,000 shares (grant or award)
  2. 4 Grant or award Director acquired 45,000 shares (grant or award)
  3. 4 Open-market sale Chief Executive Officer sold 13,353 shares at $0.58 ($7,745)
  4. 4 Open-market sale Chief Commercial Officer sold 2,563 shares at $0.58 ($1,487)
  5. 4 Grant or award Director acquired 10,416 shares (grant or award)
  6. 3 Insider Initial Statement of Ownership
  7. 4 Open-market sale Chief Executive Officer sold 139,064 shares at $1.76 ($244,753)
  8. 4 Open-market sale Principal Accounting Officer sold 12,048 shares at $1.76 ($21,204)
  9. 4 Open-market sale SVP, CMO, Head-Res&Drug sold 41,269 shares at $1.76 ($72,633)
  10. 4 Open-market sale Chief Legal Officer sold 38,938 shares at $1.76 ($68,531)
  11. 4 Open-market sale Chief Financial Officer sold 12,052 shares at $1.76 ($21,212)
  12. 4 Grant or award Principal Accounting Officer acquired 133,333 shares (grant or award)
  13. 4 Grant or award Chief Financial Officer acquired 111,111 shares (grant or award)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Grant or award SVP, CMO, Head-Res&Drug acquired 48,224 shares (grant or award)
  16. 4 Grant or award Chief Legal Officer acquired 40,187 shares (grant or award)
  17. 4 Grant or award Chief Executive Officer acquired 147,354 shares (grant or award)
  18. 4 Grant or award Director acquired 4,249 shares (grant or award)
  19. 4 Open-market sale SVP, Chief Business Officer sold 5,360 shares at $4.08 ($21,869)
  20. 4 Open-market sale SVP, COO and CFO sold 11,001 shares at $4.08 ($44,884)

Page 3 of 41 · 806 filings